Photo-inactivation of Neisseria gonorrhoeae: A paradigm changing approach for combating antibiotic-resistant gonococcal infection
Y. Wang, Y. Baglo, R. Ferrer-Espada, X. S. Goh, K. D. Held, Y. H. Grad, Y. Gu, J. A. Gelfand, T. Dai
Abstract
Neisseria gonorrhoeae is the causative pathogen of the sexually transmitted disease gonorrhea, a disease at risk of becoming untreatable due to increasing antibiotic resistance. There is a critical need for the development of new anti-gonococcal therapies. In this study, we investigated the effectiveness of antimicrobial blue light (aBL), an innovative non-antibiotic approach, for the inactivation of antibiotic-resistant N. gonorrhoeae. Our findings indicated that aBL at 405 nm preferentially inactivated antibiotic-resistant N. gonorrhoeae over the vaginal epithelial cells. Furthermore, no genotoxicity of aBL to the vaginal epithelial cells was observed at the exposure for inactivating N. gonorrhoeae. aBL also effectively inactivated N. gonorrhoeae that had invaded into the vaginal epithelial cells. No gonococcal resistance to aBL developed after 15 successive cycles of sub-therapeutic inactivation. Endogenous aBL-active photosensitizing chromophores (porphyrins and flavins) in N. gonorrhoeae were identified and quantified using ultra performance liquid chromatography, with coproporphyrin being the most abundant endogenous porphyrin species. Taken together, aBL at 405 nm represents a potent potential treatment for gonococcal infections.\n\nOne Sentence SummaryaBL selectively inactivated antibiotic-resistant Neisseria gonorrhoeaen over normal vaginal epithelial cells.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- High-throughput bactericidal assays for monoclonal antibody screening against antimicrobial resistant Neisseria gonorrhoeae
S. Stazzoni, M. Troisi, … R. Rappuoli·bioRxiv·May 10, 2023
- Aerocavin is an antibiotic with potent and specific anti-Neisserial activity
Gleb Pishchany, Kyra E Fryling, … Jon Clardy·ACS Infectious DiseasesPeer-reviewed·Jun 12, 2026
- Environmental exposure to antibiotics drives and sustains antibiotic resistance in Neisseria gonorrhoeae: A modelling study
Ernst Schäfer, Constance Schultsz, … Rik Oldenkamp·bioRxiv·Dec 8, 2025
- Time-kill curve analysis and pharmacodynamic functions for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae
Sunniva Foerster, Magnus Unemo, … Christian L Althaus·BMC MicrobiologyPeer-reviewed·Sep 17, 2016
- Ribonucleotide reductase, a novel target for gonorrhea
J. Narasimhan, S. Letinski, … A. Branstrom·bioRxiv·Nov 19, 2020
- A new class of penicillin-binding protein inhibitors to address drug-resistant Neisseria gonorrhoeae
Tsuyoshi Uehara, Allison L. Zulli, … Stephen M. Condon·Nature MicrobiologyPeer-reviewed·Apr 8, 2026